$0.8101
-0.11-11.95%
Últ. Act.: Oct 30, 4:40 PM
TELA Bio (TELA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
TELA Bio (TELA) publicó su última previsión de mayo 12, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de para el período.
En comparación con la previsión anterior, TELA Bio elevado redujo su previsión de ingresos desde un rango anterior de $19M - $19M.
TELA Bio ha emitido 16 actualizaciones de orientación entre el noviembre 9, 2022 y el mayo 12, 2026. During this period, the company raised its outlook 5 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.18 | $-0.18 | $-0.18 | $-0.19 |
| Actual | $-0.20 | $-0.21 | $-0.17 | $-0.19 |
| Surprise | -11.1% | -16.7% | +5.56% | 0.00% |
| Revenue | ||||
| Estimate | $20.0M | $18.9M | $21.0M | $21.8M |
| Actual | $19.3M | $19.1M | $20.9M | $20.7M |
| Surprise | -3.58% | +0.84% | -0.74% | -5.17% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.17 | $-0.13 | $-0.10 | $-0.11 |
| Revenue | ||||
| Consensus | $19.8M | $21.0M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.20 | $-0.18 | -11.1 % |
| Q1 | May 12, 2026 | $-0.21 | $-0.18 | -16.7 % |
| Q4 | Mar 24, 2026 | $-0.17 | $-0.18 | 5.56 % |
| Q3 | Nov 13, 2025 | $-0.19 | $-0.19 | 0.00 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $19.29M | $20.01M | -3.58 % |
| Q1 | May 12, 2026 | $19.06M | $18.90M | 0.84 % |
| Q4 | Mar 24, 2026 | $20.87M | $21.02M | -0.74 % |
| Q3 | Nov 13, 2025 | $20.70M | $21.83M | -5.17 % |